About the Authors:
David H Abramson, MD, FACS
Dr. Abramson is a board-certified ophthalmologist with specialty training in ophthalmic oncology and is the Chief of the Ophthalmic Oncology Service at Memorial Sloan Kettering Cancer Center. He treats patients with intraocular tumors such as: uveal melanoma and retinoblastoma and our patients have access to novel therapies and clinical trials not available anywhere else in the country. He has introduced many new treatments for retinoblastoma including ophthalmic artery chemosurgery. He has published more than 700 books, chapters, original articles, scientific reviews, audiotapes, and videotapes, and was the editor of the American Academy of Ophthalmology’s instruction book on ophthalmic oncology. He has delivered more than 500 lectures worldwide, including those in France, Italy, England, Switzerland, Israel, China, Hong Kong, Canada, Mexico, Venezuela, Peru, Brazil, and Argentina. Among the many honors he has received, are awards from the Swiss Society of Ophthalmology, the Association for Research in Vision and Ophthalmology, the Helen Keller Services for the Blind, and the New York State Ophthalmological Society. He has received many teaching awards and received the Honor Award, the Senior Honor Award, and the Lifetime Achievement Award from the American Academy of Ophthalmology.